Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
University of Texas MD Anderson Cancer Center researchers have demonstrated that the prostate basal cell layer contains self-renewing adult stem cells, ... Read more
Post-biopsy infection and sepsis rates are significantly higher in groups of patients given empirical fluoroquinolone prophylaxis when compared to those who receive ... Read more
Thomas Jefferson University researchers recently tested a new imaging technique to detect prostate cancer cells and malignant lesions — a technique they also ... Read more
Regular aspirin use in men with prostate cancer is potentially associated with a reduced risk of prostate cancer-specific deaths, according to ... Read more
Surgery is more effective than radiation therapy at treating localized prostate cancer and more likely to prolong the life of patients undergoing ... Read more
A new Phase 3 clinical study, the EORTC trial 1333, will compare the combination treatment of enzalutamide and RA-223, versus enzalutamide alone, ... Read more
A phase II trial evaluating combination of radiotherapy and an experimental treatment driving tumor cells to self-destruct achieved promising results in cancer ... Read more
A large-scale analysis of medical records revealed that men undergoing androgen deprivation therapy for prostate cancer treatment may be at almost twice ... Read more
GenomeDx Biosciences, a genomic information company that develops and commercializes clinical tests using great amounts of genomic data, has announced the ... Read more
